Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The Nottingham Prognostic Index in primary breast cancer.

Galea MH, Blamey RW, Elston CE, Ellis IO.

Breast Cancer Res Treat. 1992;22(3):207-19.

PMID:
1391987
2.

The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT.

Breast Cancer Res Treat. 1994;32(3):281-90.

PMID:
7865856
3.

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy.

Borger JH, van Tienhoven G, Passchier DH, Hart AA, van Dongen JA, Rutgers EJ, Bartelink H.

Radiother Oncol. 1992 Sep;25(1):1-11.

PMID:
1410583
4.

Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.

Okugawa H, Yamamoto D, Uemura Y, Sakaida N, Yamada M, Tanaka K, Kamiyama Y.

Surg Today. 2005;35(11):907-11. Retraction in: Surg Today. 2009;39(8):738.

PMID:
16249842
5.

The prognosis of small primary breast cancers.

Kollias J, Murphy CA, Elston CW, Ellis IO, Robertson JF, Blamey RW.

Eur J Cancer. 1999 Jun;35(6):908-12.

PMID:
10533470
6.
7.

[The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].

Jakić-Razumović J, Corić M, Vrbanec D, Babić D, Hlupić L, Belev B.

Lijec Vjesn. 2005 Jan-Feb;127(1-2):3-7. Croatian.

PMID:
16145866
8.

Early-onset breast cancer--histopathological and prognostic considerations.

Kollias J, Elston CW, Ellis IO, Robertson JF, Blamey RW.

Br J Cancer. 1997;75(9):1318-23.

9.

Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group.

Sundquist M, Thorstenson S, Brudin L, Nordenskjöld B.

Breast Cancer Res Treat. 1999 Jan;53(1):1-8.

PMID:
10206067
10.

LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.

Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.

Anticancer Res. 2004 Jul-Aug;24(4):2391-400.

11.

Prognostic significance of synchronous and metachronous bilateral breast cancer.

Kollias J, Ellis IO, Elston CW, Blamey RW.

World J Surg. 2001 Sep;25(9):1117-24.

PMID:
11571945
12.

Prognosis based on primary breast carcinoma instead of pathological nodal status.

Ménard S, Bufalino R, Rilke F, Cascinelli N, Veronesi U, Colnaghi MI.

Br J Cancer. 1994 Oct;70(4):709-12.

13.

Factors affecting survival in breast cancer patients following bone metastasis.

Yavas O, Hayran M, Ozisik Y.

Tumori. 2007 Nov-Dec;93(6):580-6.

14.

A modified Nottingham prognostic index for breast cancer patients diagnosed in Denmark 1978-1994.

Rostgaard K, Mouridsen HT, Vaeth M, Holst H, Olesen KP, Lynge E.

Acta Oncol. 2001;40(7):838-43.

PMID:
11859983
15.

Survival from operable breast cancer: prognostic factors in Yogyakarta, Indonesia.

Aryandono T, Harijadi, Soeripto.

Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):455-9.

16.
17.

Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.

Horita K, Yamaguchi A, Hirose K, Ishida M, Noriki S, Imamura Y, Fukuda M.

Eur J Histochem. 2001;45(1):73-84.

PMID:
11411868
18.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
19.

High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.

Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG.

Breast Cancer Res. 2005;7(5):R780-7.

20.

Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.

Jiang WG, Douglas-Jones AG, Mansel RE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):125-34.

PMID:
16364620
Items per page

Supplemental Content

Support Center